Increasing adolescent vaccination coverage: The challenges that remain

Archives of Pediatrics and Adolescent Medicine

Volumn 165, Issue 6, 2011, Pages 568-570

  Stokley, Shannon ^a   Vogt, Tara ^a   Shefer, Abigail ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGITIS VACCINE; PERTUSSIS VACCINE; WART VIRUS VACCINE;

ADOLESCENT; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; EDITORIAL; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE PRACTICE; HEALTH PERSONNEL ATTITUDE; HEALTH SERVICE; HUMAN; IMMUNITY; IMMUNIZATION; MENINGITIS; PARENTAL ACCEPTANCE; PARENTAL CONSENT; PERTUSSIS; PREVENTIVE MEDICINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; VACCINATION; VERRUCA VULGARIS;

ADOLESCENT; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INSURANCE COVERAGE; MALE; NEEDS ASSESSMENT; PATIENT ACCEPTANCE OF HEALTH CARE; PROGRAM EVALUATION; RISK ASSESSMENT; UNITED STATES; VACCINATION;

EID: 79958054590     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2011.65     Document Type: Editorial

References (27)

1. Bilukha OO, Rosenstein N; National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2005;54(RR-7):1-21.
2. Broder KR, Cortese MM, Iskander JK, et al; Advisory Committee on Immunization Practices (ACIP). Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-3):1-34.
3. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-2):1-24.
4. Centers for Disease Control and Prevention (CDC). National, state, and local area vaccination coverage among adolescents aged 13-17 years - United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59(32):1018-1023.
5. Szilagyi PG, Humiston SG, Gallivan S, Albertin C, Sandler M, Blumkin A. Effectiveness of a citywide patient immunization navigator program on improving adolescent immunizations and preventive care visit rates. Arch Pediatr Adolesc Med. 2011;165(6):547-553.
6. Rodewald LE, Szilagyi PG, Humiston SG, Barth R, Kraus R, Raubertas RF. A randomized study of tracking with outreach and provider prompting to improve immunization coverage and primary care. Pediatrics. 1999;103(1):31-38. (Pubitemid 29281925)
7. Smith PJ, Lindley MC, Shefer A, Rodewald LE. Underinsurance and adolescent immunization delivery in the United States. Pediatrics. 2009;124(suppl 5):S515-S521.
8. Smith PJ, Molinari NA, Rodewald LE. Underinsurance and pediatric immunization delivery in the United States. Pediatrics. 2009;124(suppl 5):S507-S514.
9. Lu PJ, Jain N, Cohn AC. Meningococcal conjugate vaccination among adolescents aged 13-17 years, United States, 2007. Vaccine. 2010;28(11):2350- 2355.
10. Caskey R, Lindau ST, Alexander GC. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health. 2009;45(5):453-462.
11. Freed GL, Clark SJ, Butchart AT, Singer DC, Davis MM. Parental vaccine safety concerns in 2009. Pediatrics. 2010;125(4):654-659.
12. Rosenthal SL, Rupp R, Zimet GD, et al. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health. 2008;43(3):239-245.
13. Daley MF, Crane LA, Markowitz LE, et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics. 2010;126(3):425-433.
14. Kahn JA, Cooper HP, Vadaparampil ST, et al. Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev. 2009;18(8):2325-2332.
15. Clark SJ, Cowan AE, Stokley S, Bilukha O, Davis MM. Physician perspectives to inform a new recommendation for meningococcal conjugate vaccine (MCV4). J Adolesc Health. 2006;39(6):850-855. (Pubitemid 44751500)
16. Humiston SG, Albertin C, Schaffer S, et al. Health care provider attitudes and practices regarding adolescent immunizations: a qualitative study. Patient Educ Couns. 2009;75(1):121-127.
17. Kempe A. Adolescent meningococcal vaccine: physicians' current practices and preferences. Presented at the Advisory Committee on Immunization Practices Meeting, October 2010, Atlanta, GA. http://www.cdc.gov/vaccines/recs/acip/ downloads/mtg-slides-oct10/02-4-mening-attitudes.pdf. Accessed on November 18, 2010.
18. National Vaccine Advisory Committee. Standards for child and adolescent immunization practices. Pediatrics. 2003;112(4):958-963.
19. Stokley S. Update: HPV vaccination coverage among U.S. adolescent females. Presented at the Advisory Committee on Immunization Practices Meeting, October 2010, Atlanta, GA. http://www.cdc.gov/vaccines/recs/acip/downloads/mtg- slides-oct10/08-3-hpv-Female.pdf. Accessed on November 18, 2010.
20. Smith PJ, Kennedy AM, Wooten K, Gust DA, Pickering LK. Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage. Pediatrics. 2006;118(5):e1287-e1292. (Pubitemid 46393633)
21. Freed GL, Cowan AE, Gregory S, Clark SJ. Variation in provider vaccine purchase prices and payer reimbursement. Pediatrics. 2009;124(suppl 5):S459-S465.
22. National Vaccine Advisory Committee. Financing vaccination of children and adolescents: National Vaccine Advisory Committee recommendations. Pediatrics. 2009;124(suppl 5):S558-S562.
23. Saville AW, Albright K, Nowels C, et al. Getting under the hood: exploring issues that affect provider-based recall using an immunization information system. Acad Pediatr. 2011;11(1):44-49.
24. Task Force on Community Preventive Services. Recommendations regarding interventions to improve vaccination coverage in children, adolescents, and adults. Am J Prev Med. 2000;18(1)(suppl):92-96.
25. Task Force on Community Preventive Services. Updated reviews of the Community Guide. Available at: http://www.thecommunityguide.org/about/ Conclusion-Report-071210.pdf. Accessed November 29, 2010.
26. Centers for Disease Control and Prevention (CDC). Updated recommendations for use of meningococcal conjugate vaccines - Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep. 2011;60(3):72-76.
27. US Department of Health and Human Services. Objective IID-11: increase routine vaccination coverage levels for adolescents. Healthy People 2020 Summary of Objectives: Immunization and Infectious Diseases. http://www.healthypeople. gov/2020/topicsobjectives2020/pdfs/Immunization.pdf. Accessed December 14, 2010.